The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or mixture thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.
申请公布号
CA2620621(A1)
申请公布日期
2007.03.01
申请号
CA20062620621
申请日期
2006.08.28
申请人
VERTEX PHARMACEUTICALS INCORPORATED
发明人
LE TIRAN, ARNAUD;PEROLA, EMANUELE;GRILLOT, ANNE-LAURE;COTTRELL, KEVIN M.;TANG, QING;MAXWELL, JOHN
